These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 24360911)

  • 41. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
    Quinlan DJ; Eriksson BI
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New oral anticoagulants for treatment of venous thromboembolism].
    Espinola-Klein C; Weisser G
    Dtsch Med Wochenschr; 2011 Jun; 136(22):1162-4. PubMed ID: 21611919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The newer anticoagulants in thrombosis control in cancer patients.
    den Exter PL; van der Hulle T; Klok FA; Huisman MV
    Semin Oncol; 2014 Jun; 41(3):339-45. PubMed ID: 25023349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of direct oral anticoagulants for the treatment of venous thromboembolism in the oncology population.
    Hedvat J; Howlett C; McCloskey J; Patel R
    J Thromb Thrombolysis; 2018 Nov; 46(4):483-487. PubMed ID: 30191357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.
    Franco-Moreno A; Cabezón-Gutiérrez L; Palka-Kotlowsa M; Villamayor-Delgado M; García-Navarro M
    J Thromb Thrombolysis; 2019 Apr; 47(3):409-419. PubMed ID: 30467760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of Venous Thromboembolism With New Anticoagulant Agents.
    Becattini C; Agnelli G
    J Am Coll Cardiol; 2016 Apr; 67(16):1941-55. PubMed ID: 27102510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Treatment of Venous Thromboembolism in Patients with Cancer.
    Prandoni P
    Adv Exp Med Biol; 2017; 906():123-135. PubMed ID: 27620308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive update on the prevention and treatment of venous thromboembolism in cancer patients.
    Tagalakis V; Wharin C; Kahn SR
    Semin Thromb Hemost; 2013 Mar; 39(2):127-40. PubMed ID: 23386467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer-associated venous thrombosis in the surgical setting.
    Behranwala KA; Williamson RC
    Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
    Tran QN
    Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.
    Phelps MK; Wiczer TE; Erdeljac HP; Van Deusen KR; Porter K; Philips G; Wang TF
    J Oncol Pharm Pract; 2019 Jun; 25(4):793-800. PubMed ID: 29460705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
    Khorana AA; Yannicelli D; McCrae KR; Milentijevic D; Crivera C; Nelson WW; Schein JR
    Thromb Res; 2016 Sep; 145():51-3. PubMed ID: 27485998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism.
    Chan NC; Bhagirath V; Eikelboom JW
    Vasc Health Risk Manag; 2015; 11():343-51. PubMed ID: 26170684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What are the pharmacotherapy options for treating venous thromboembolism in cancer patients?
    Prandoni P; Piovella C; Filippi L; Vedovetto V; Dalla Valle F; Piccioli A
    Expert Opin Pharmacother; 2014 Apr; 15(6):799-807. PubMed ID: 24548179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis.
    Attard LM; Gatt A; Bertoletti L; Delluc A; Riva N
    Vasc Health Risk Manag; 2022; 18():793-807. PubMed ID: 36268462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.
    van Es N; Bleker SM; Wilts IT; Porreca E; Di Nisio M
    Drugs; 2016 Mar; 76(3):331-41. PubMed ID: 26729187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Oral anticoagulants for primary and secondary prevention of venous thromboembolism].
    Gavorník P; Dukát A; Gašpar Ľ; Gubo G; Hučková N
    Vnitr Lek; 2016; 62(9):746-750. PubMed ID: 27715076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low-molecular-weight heparin in oncology.
    Zacharski LR; Loynes JT
    Anticancer Res; 2003; 23(3C):2789-93. PubMed ID: 12926114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Direct oral anticoagulants in the treatment of cancer-associated thrombosis].
    Stebler-Fontaine L; Rossel A; Marti C; Righini M; Robert-Ebadi H
    Rev Med Suisse; 2019 Dec; 15(674):2232-2235. PubMed ID: 31804034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?
    Verso M; Franco L; Giustozzi M; Becattini C; Agnelli G
    Thromb Res; 2018 Apr; 164 Suppl 1():S168-S171. PubMed ID: 29703477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.